Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Stroke D020521 32 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Thrombophilia D019851 6 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Sepsis D018805 11 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Osteoblastoma D018215 1 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
beta-Thalassemia D017086 5 associated lipids
Carotid Stenosis D016893 15 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Yang Deficiency D016711 3 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bacteremia D016470 9 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Reperfusion Injury D015427 65 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Wounds and Injuries D014947 20 associated lipids
Weil Disease D014895 2 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Yin K et al. Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils. 1992 Br. J. Pharmacol. pmid:1393269
Zhang JY and Luo LL [Intrauterine device-induced menorrhagia and endometrial content of prostacyclins]. 1992 Zhonghua Fu Chan Ke Za Zhi pmid:1395902
Wang M [Studies on plasma beta-thromboglobulin, thromboxane A2, prostaglandin I2 concentration and platelet count in liver diseases]. 1992 Zhonghua Nei Ke Za Zhi pmid:1395919
Mei XW et al. [The interaction of some active and immunological factors in blood in the development of chronic cor pulmonale]. 1992 Zhonghua Nei Ke Za Zhi pmid:1395928
Watson ED et al. Arachidonate metabolites in bronchoalveolar lavage fluid from horses with and without COPD. 1992 Equine Vet. J. pmid:1396512
Pretolani M et al. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs. 1992 Eur. J. Pharmacol. pmid:1397002
Goldman G et al. Reactive oxygen species and elastase mediate lung permeability after acid aspiration. 1992 J. Appl. Physiol. pmid:1399982
Koizumi T et al. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep. 1992 J. Appl. Physiol. pmid:1399989
Coffee KA et al. Endotoxin tolerance is associated with altered GTP-binding protein function. 1992 J. Appl. Physiol. pmid:1400011
Weber C et al. Gas chromatographic-mass spectrometric determination of 11-dehydrothromboxane B2 in human urine. 1992 J. Chromatogr. pmid:1400727
Abramson MM et al. Flurbiprofen effect on gingival crevicular fluid prostaglandin and thromboxane levels in humans. 1992 J. Periodont. Res. pmid:1403584
Altavilla D et al. Protective effects of endotoxin tolerance in tumor bearing rats. 1992 Pharmacol. Res. pmid:1409293
Ferretti A et al. GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1409763
Stier CT et al. Enhanced thromboxane formation by blood but not whole platelets from spontaneously hypertensive rats. 1992 Prostaglandins pmid:1410518
Rabinovici R et al. Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock. 1992 Surg Gynecol Obstet pmid:1411892
Husted SE et al. Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males. 1992 Thromb. Haemost. pmid:1412171
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Yue TL et al. Pharmacological profile of G619, a new platelet aggregation inhibitor. 1992 Thromb. Res. pmid:1412200
Tohgi H et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. 1992 Stroke pmid:1412574
Santillan-Doherty P et al. Urinary thromboxane B2 excretion during acute rejection in cyclosporine-treated experimental lung allotransplantation. 1992 Transplant. Proc. pmid:1412957
Atzori L et al. Vasoconstriction and bronchoconstriction induced by 2,5-di-(tert-butyl)1,4-benzohydroquinone, an endoplasmic reticular Ca2+-ATPase inhibitor, in isolated and perfused rat lung. 1992 Agents Actions pmid:1414686
Diss EM et al. Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. 1992 Am. J. Obstet. Gynecol. pmid:1415390
Wang Y et al. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. 1992 Am. J. Obstet. Gynecol. pmid:1415430
Martin SE et al. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2. 1992 Am. J. Physiol. pmid:1415751
Matsumoto M et al. Lung traction causes an increase in plasma prostacyclin concentration and decrease in mean arterial blood pressure. 1992 Anesth. Analg. pmid:1416133
Mistakopulo NF et al. [The effect of indomethacin and leukinferon on the level of blood plasma thromboxane B2, platelet aggregation and the immune system of patients with endometrial cancer in the perioperative period]. 1992 Mar-Apr Anesteziol Reanimatol pmid:1416192
Gershwin LJ and Giri SN Effects of allergen challenge on plasma concentrations of prostaglandins, thromboxane B2, and histamine in calves infected with bovine respiratory syncytial virus. 1992 Am. J. Vet. Res. pmid:1416375
Miller RF et al. Effect of sulfidopeptide leukotriene receptor antagonists on endotoxin-induced pulmonary dysfunction in awake sheep. 1992 Am. Rev. Respir. Dis. pmid:1416431
Lloret S and Moreno JJ In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. 1992 Biochem. Pharmacol. pmid:1417964
Beitz J et al. Influence of HDL on the formation of 6-keto-PGF1 alpha and TXB2 in vitro: the importance of the source of HDL. 1992 Eicosanoids pmid:1419081
Surya II et al. Enhancement of platelet functions by low density lipoproteins. 1992 Biochim. Biophys. Acta pmid:1420343
RÃ¥ngemark C et al. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. 1992 Circulation pmid:1423963
Hui SC et al. Arachidonic acid metabolism in nicotine-treated rats and nicotine-incubated rabbit aortic smooth muscle cells. 1992 Clin. Exp. Pharmacol. Physiol. pmid:1424297
Hoshino H et al. Mechanism and prevention of chronic colonic inflammation with trinitrobenzene sulfonic acid in rats. 1992 Clin. Exp. Pharmacol. Physiol. pmid:1424301
Cagossi M et al. Effects of various prostaglandin synthesis inhibitors on the tone of the lower oesophageal sphincter in man. 1992 Eur. J. Clin. Pharmacol. pmid:1425897
Evangelista V et al. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G. 1992 Eur. J. Pharmacol. pmid:1425930
Chen MF et al. Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits. 1992 Int. J. Cardiol. pmid:1428263
Brenner T et al. Glucocorticoid regulation of eicosanoid production by glial cells under basal and stimulated conditions. 1992 J. Neuroimmunol. pmid:1430157
Kunievsky B and Yavin E Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo. 1992 J. Pharmacol. Exp. Ther. pmid:1432689
Soma LR et al. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production. 1992 J. Vet. Pharmacol. Ther. pmid:1433493
Hattori T et al. Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis. 1992 Jpn. J. Pharmacol. pmid:1434112
Wagner B et al. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo. 1992 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1436129
Nadasy GL et al. Pharmacological modulation of prostacyclin and thromboxane production of rat and cat venous tissue slices. 1992 Prostaglandins pmid:1438884
Weide I et al. Effects of cyclooxygenase inhibitors on ex vivo cysteinyl-leukotriene production by whole human blood allowed to clot spontaneously. Comparison to stimulated blood. 1992 Thromb. Res. pmid:1440511
Sirén AL et al. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. 1992 Stroke pmid:1440713
Halt PS et al. Alcohol exacerbates behavioral and neurochemical effects of rat spinal cord trauma. 1992 Arch. Neurol. pmid:1444885
Kawada T et al. Pretreatment with catalase or dimethyl sulfoxide protects alloxan-induced acute lung edema in dogs. 1992 J. Appl. Physiol. pmid:1447076
Udvardy M et al. Altered primary haemostasis in Conn's syndrome. 1992 Thromb. Res. pmid:1448795
Rasmanis G et al. Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction. 1992 Br Heart J pmid:1449919
Szebeni J et al. Complement activation during hemorrhagic shock and resuscitation in swine. 2003 Shock pmid:14501949